Pharmacopoeias

About 20 countries have Pharmacopoeias out of the 200 countries. They operate with varying degrees of autonomy with their regulatory agencies. Many are part of the government, and work in close association with their regulatory agency, e.g. Japan, China, Brazil, Mexico and the Russian Federation. The European Pharmacopoeia in Europe is elaborated by the European Pharmacopoeia Commission, which draws its membership from the countries participating in the Council of Europe (and not the European Union). The British Pharmacopoeia may be able to remain in the Council of Europe. The US Pharmacopoeial Convention operates as a private non-profit body in the US (separate from the FDA). The USP was created in 1820 whereas the FDA was created in the early 20th Century. Pharmacopoeias began working together in harmony in the early 1990s.

print

Leave a Reply

Your email address will not be published. Required fields are marked *